Literature DB >> 16424387

Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells.

Wu Xu1, Tomofusa Fukuyama, Paul A Ney, Demin Wang, Jerold Rehg, Kelli Boyd, Jan M A van Deursen, Paul K Brindle.   

Abstract

CREB-binding protein (CBP) and its para-log p300 are transcriptional coactivators that physically or functionally interact with over 320 mammalian and viral proteins, including 36 that are essential for B cells in mice. CBP and p300 are generally considered limiting for transcription, yet their roles in adult cell lineages are largely unknown since homozygous null mutations in either gene or compound heterozygosity cause early embryonic lethality in mice. We tested the hypotheses that CBP and p300 are limiting and that each has unique properties in B cells, by using mice with Cre/LoxP conditional knockout alleles for CBP (CBP(flox)) and p300 (p300(flox)), which carry CD19(Cre) that initiates floxed gene recombination at the pro-B-cell stage. CD19(Cre)-mediated loss of CBP or p300 led to surprisingly modest deficits in B-cell numbers, whereas inactivation of both genes was not tolerated by peripheral B cells. There was a moderate decrease in B-cell receptor (BCR)-responsive gene expression in CBP or p300 homozygous null B cells, suggesting that CBP and p300 are essential for this signaling pathway that is crucial for B-cell homeostasis. These results indicate that individually CBP and p300 are partially limiting beyond the pro-B-cell stage and that other coactivators in B cells cannot replace their combined loss.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424387      PMCID: PMC1895794          DOI: 10.1182/blood-2005-08-3263

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  CREB-binding protein and p300 in transcriptional regulation.

Authors:  N Vo; R H Goodman
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  CBP and p300: versatile coregulators with important roles in hematopoietic gene expression.

Authors:  Gerd A Blobel
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

3.  The HOX homeodomain proteins block CBP histone acetyltransferase activity.

Authors:  W F Shen; K Krishnan; H J Lawrence; C Largman
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells.

Authors:  Kenji Tanigaki; Hua Han; Norio Yamamoto; Kei Tashiro; Masaya Ikegawa; Kazuki Kuroda; Akira Suzuki; Toru Nakano; Tasuku Honjo
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

5.  Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

Authors:  Bansri Furia; Longwen Deng; Kaili Wu; Shanese Baylor; Kylene Kehn; Hong Li; Robert Donnelly; Tim Coleman; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

6.  The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells.

Authors:  Alexander V Emelyanov; Cecilia R Kovac; Manuel A Sepulveda; Barbara K Birshtein
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

7.  Interaction between the hematopoietic Ets transcription factor Spi-B and the coactivator CREB-binding protein associated with negative cross-talk with c-Myb.

Authors:  Hitomi Yamamoto; Fumiko Kihara-Negishi; Toshiyuki Yamada; Mitsuhiro Suzuki; Tohru Nakano; Tsuneyuki Oikawa
Journal:  Cell Growth Differ       Date:  2002-02

8.  Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

Authors:  Jörg Vervoorts; Juliane M Lüscher-Firzlaff; Sabine Rottmann; Richard Lilischkis; Gesa Walsemann; Karen Dohmann; Matthias Austen; Bernhard Lüscher
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

9.  NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction.

Authors:  Georgia Mandolesi; Silvia Gargano; Maria Pennuto; Barbara Illi; Rosa Molfetta; Laura Soucek; Laura Mosca; Andrea Levi; Richard Jucker; Sergio Nasi
Journal:  FEBS Lett       Date:  2002-01-02       Impact factor: 4.124

10.  Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow.

Authors:  Z Hao; K Rajewsky
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  42 in total

Review 1.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

2.  Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Authors:  Yujie Liu; Liqing Wang; Rongxiang Han; Ulf H Beier; Tatiana Akimova; Tricia Bhatti; Haiyan Xiao; Philip A Cole; Paul K Brindle; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

3.  TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Authors:  Ali I Kuraishy; Samuel W French; Mara Sherman; Marco Herling; Dan Jones; Randolph Wall; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

4.  Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia.

Authors:  Douglas J Hilton; Benjamin T Kile; Warren S Alexander
Journal:  Blood       Date:  2009-02-27       Impact factor: 22.113

Review 5.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 6.  Epigenetic alterations in hematopoietic malignancies.

Authors:  Young Rock Chung; Emma Schatoff; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2012-09-27       Impact factor: 2.490

Review 7.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

8.  The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.

Authors:  Jiyuan Zhang; Sofija Vlasevska; Victoria A Wells; Sarah Nataraj; Antony B Holmes; Romain Duval; Stefanie N Meyer; Tongwei Mo; Katia Basso; Paul K Brindle; Shafinaz Hussein; Riccardo Dalla-Favera; Laura Pasqualucci
Journal:  Cancer Discov       Date:  2017-01-09       Impact factor: 39.397

Review 9.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

10.  Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

Authors:  Jernej Murn; Olivier Alibert; Ning Wu; Simon Tendil; Xavier Gidrol
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.